Sign in

Alzheimer disease

Current status: No cure yet

A brain disease that slowly harms memory and thinking, and the most common cause of dementia in older people. Medicines cannot stop it, but some can keep the symptoms from getting worse for a while. Most people who get it are over 65, and the risk rises with age: about 1 in 6 people over 80 has it or another type of dementia. The changes in the brain start many years before the first signs appear.

Read more about Alzheimer disease
Where research stands todayUpdated 17 Nov 2026

Trial-stage treatments and research studies you can joinOpen trials for referral

Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.

Filters

Country
City
Distance is calculated in your browser. Your city is not sent to us.
Type
Get notified of new trialsEstonia, all cities, all phases
Your ageShows only trials that take people your age.
Phase

Trials that have ended are not listed here, because nobody can join them. Stopped and finished Alzheimer disease trials (research view)

Take part in research

19 official research programmes take people with this disease. In a biobank or a registry you give a blood or tissue sample, or your health data, for many research teams to use.

See the research programmes

Search the publications

The results open on the publications page in a new tab, so this page stays as it is.

Lists with this disease filtered

Where treatment stands

In the EU, lecanemab was first approved in April 2025 and donanemab in September 2025.

Approved: 12

Officially approved for this disease in the EU, the US, Switzerland or France.

Human testing stage: 29

Being tested in people. Many treatments at this stage are never approved.

Animal testing stage: 5

Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.

Lab research stage: 1

Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.

Words used here

Placebo: a dummy treatment without the medicine, used for comparison.

Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.

Where this comes from

The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.

A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.

The EU medicines agency (EMA), ClinicalTrials.gov and the EU trials register, checked on 10 November 2026. Every treatment links to its own records; the texts are written by AI from them.

Medicines approved only in single countries are not included. We did not check in which countries a medicine is sold or paid for. Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 99 other open phase 2 trials are not listed.

Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for Alzheimer's disease. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.

Not medical advice. Talk to your doctor before you change any treatment.

The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.

Support organisations

Patient organisations and helplines in Estonia, for you and your family.

Alzheimer disease organisations in Estonia

  • Dementsuse Kompetentsikeskus – dementsuse info- ja usaldusliin

    Dementia Competence Centre: info and trust line, personal expert counselling for people with dementia and relatives, support groups for relatives.

  • Elu Dementsusega

    NGO founded in 2016 that brings together people close to someone with dementia and dementia professionals to improve the lives of people with dementia and their families in Estonia; Alzheimer Europe full member.

General support in Estonia

  • Ohvriabi emotsionaalse toe telefon 116 123

    Free emotional support helpline 116 123 of the Estonian Social Insurance Board: counsellors support anyone in distress every day 10:00–24:00.

  • Perearsti nõuandeliin 1220

    Estonia's nationwide 24/7 health advice line where doctors and nurses advise callers on health problems and where to seek care.

International organisations

  • Alzheimer's Association

    Free 24/7 Helpline (interpreters for 200+ languages), care consultations with dementia experts, local chapters, Community Resource Finder, ALZConnected online community.

  • Alzheimer's Drug Discovery Foundation

    Funds the early work on new Alzheimer's medicines, in universities and companies.

  • BrightFocus Foundation

    US nonprofit that funds research and provides public information on Alzheimer's disease, macular degeneration and glaucoma.

  • Dementia Alliance International (DAI)

    Organisation for people with a dementia diagnosis: free online peer support groups, webinars, Brain Health Hub, resources for care partners.

Patient organisation umbrella bodies

Offer tissue or data

There are three ways to help research move faster.

Give tissue or bloodA biobank stores your sample so many research teams can use it.No open programme yet
Share your health dataA patient registry collects your health data, without your name, for research.How to join
Take part as a healthy volunteerStudies also need people without the disease, for comparison. Family and friends can help.Volunteer

Approved treatments

12 medicines are approved for Alzheimer disease in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.

Checked on 11 Nov 2026 in the official lists of the US (FDA), the EU (EMA), Japan (PMDA, approvals since April 2004), Switzerland (Swissmedic), France (ANSM, medicines approved in France only) and Taiwan (TFDA). For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. 4 uncertain matches are left out. Other countries' own approvals were not checked.

“Miracle cure” fact checker

Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.

What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.

Before you pay for anything, ask three things

  1. Is there a published study in people?
  2. Can I have the full price in writing?
  3. What does my doctor say?

“Cures” others already fact-checked

See all 1

About Alzheimer disease

Sources: NHS, MedlinePlus, Archives of Neurology

A brain disease that slowly harms memory and thinking, and the most common cause of dementia in older people. Medicines cannot stop it, but some can keep the symptoms from getting worse for a while. Most people who get it are over 65, and the risk rises with age: about 1 in 6 people over 80 has it or another type of dementia. The changes in the brain start many years before the first signs appear.

What is it?

Alzheimer's is the most common cause of dementia: a steady loss of memory, thinking and other mental abilities. Proteins build up in and around brain cells. One protein (amyloid) forms clumps around the cells, another (tau) forms tangles inside them. Over time parts of the brain shrink, usually the memory areas first. These changes begin many years before any signs. It is not a normal part of getting older.

Most people who get it are over 65, and the risk rises with age: about 1 in 14 people over 65 and 1 in 6 over 80 have Alzheimer's or another type of dementia. Genes usually raise the risk only a little. In a few families a single gene causes it, and then it is much more likely to be passed on.

The first signs

The signs come on slowly over several years and are sometimes taken for normal ageing.

  • forget recent conversations or events;
  • misplace things and forget the names of places and objects;
  • struggle to find the right word, or ask the same questions again and again;
  • find decisions harder and become more hesitant about trying new things;
  • feel anxious, agitated or confused at times.

How doctors find out

There is no simple, reliable test. The doctor checks your general health, may order blood tests and ask about your medicines to rule out other causes, and asks you to do some memory and thinking tasks. You may then be sent to a specialist, who may work at a memory clinic, for more tests such as a brain scan (CT or MRI). Finding out can take many months and several appointments.

Current treatment

Symptom medicines (e.g. donepezil) plus support

Will it get worse?

Yes. It is a progressive illness: the symptoms get worse slowly over several years. It gets worse slowly, at a different pace for each person. In the middle stage people usually need support with everyday living, such as help with eating, washing, getting dressed and using the toilet. In the severe stages they may need full-time care. People may live for several years after the signs begin, but this varies a lot. Alzheimer's shortens life, though many people with it die of something else.

Medicines: what helps, and what to watch for

Medicines cannot cure Alzheimer's, but some can ease the symptoms for a time. Donepezil, galantamine and rivastigmine raise acetylcholine, a brain chemical that helps nerve cells pass messages; they are used in the early and middle stages. Memantine works in a different way and is used when the disease is moderate or severe.

Good to know:

  • specialists, such as psychiatrists or neurologists, can prescribe these medicines; your family doctor may prescribe them on a specialist's advice;
  • feeling sick, being sick and losing your appetite can be side effects, and they usually get better after about 2 weeks;
  • memantine can cause headaches, dizziness and constipation, which usually pass;
  • for aggression or extreme distress, other ways of coping are tried first; antipsychotic medicines have serious side effects, so they should be used at the lowest dose for the shortest time possible.

Exercise and therapy help too

Some treatments without medicines can help memory, problem solving, mood and wellbeing:

  • cognitive stimulation therapy: group activities and exercises for memory and problem solving;
  • cognitive rehabilitation: working with a professional, such as an occupational therapist, and a relative or friend towards a personal goal, like using a mobile phone;
  • reminiscence and life story work: talking about the past with the help of photos, objects or music.

Exercise regularly, for example with a daily walk, gardening, tai chi or dancing.

Is there a cure?

Not yet. No treatment can stop the disease today.

See the 899 trials you can join

Median survival

About 3 to 8 years after diagnosis, depending on age at diagnosis

Measured in: Participants of the Baltimore Longitudinal Study of Aging older than 55, followed 1985–1999

The figures behind it

Baltimore Longitudinal Study of Aging (participants older than 55, followed 1985–1999): median survival 8.3 years when Alzheimer disease was diagnosed at age 65, down to 3.4 years when it was diagnosed at age 90; no significant difference between men and women.